174 related articles for article (PubMed ID: 36279032)
1. Predictive model for autonomous cortisol secretion development in non-functioning adrenal incidentalomas.
Araujo-Castro M; García Cano AM; Escobar-Morreale HF; Valderrabano P
Hormones (Athens); 2023 Mar; 22(1):51-59. PubMed ID: 36279032
[TBL] [Abstract][Full Text] [Related]
2. Is the 1mg-dexamethasone suppression test a precise marker of glucocorticoid excess and cardiometabolic risk in patients with adrenal incidentalomas?
Araujo-Castro M; Hanzu FA; Pascual-Corrales E; García Cano AM; Marchan M; Escobar-Morreale HF; Valderrabano P; Casals G
Endocrine; 2023 Oct; 82(1):161-170. PubMed ID: 37351760
[TBL] [Abstract][Full Text] [Related]
3. Accuracy of the dexamethasone suppression test for the prediction of autonomous cortisol secretion-related comorbidities in adrenal incidentalomas.
Araujo-Castro M; Parra Ramírez P; Robles Lázaro C; García Centeno R; Gracia Gimeno P; Fernández-Ladreda MT; Sampedro Núñez MA; Marazuela M; Escobar-Morreale HF; Valderrabano P
Hormones (Athens); 2021 Dec; 20(4):735-744. PubMed ID: 34273083
[TBL] [Abstract][Full Text] [Related]
4. Nonfunctioning adrenal incidentalomas with cortisol post-dexamethasone suppression test >0.9 µg/dL have a higher prevalence of cardiovascular disease than those with values ≤0.9 µg/dL.
Araujo-Castro M; Parra Ramírez P; Martín Rojas-Marcos P; García Centeno R; Gracia Gimeno P; Tomé Fernández-Ladreda M; Sampedro Núñez MA; Higueruela C; Robles Lázaro C
Endocrine; 2023 Feb; 79(2):384-391. PubMed ID: 36261701
[TBL] [Abstract][Full Text] [Related]
5. Maximum adenoma diameter, regardless of uni- or bilaterality, is a risk factor for autonomous cortisol secretion in adrenal incidentalomas.
Araujo-Castro M; Robles Lázaro C; Parra Ramírez P; García Centeno R; Gracia Gimeno P; Fernández-Ladreda MT; Sampedro Núñez MA; Marazuela M; Escobar-Morreale HF; Valderrabano P
J Endocrinol Invest; 2021 Nov; 44(11):2349-2357. PubMed ID: 33683661
[TBL] [Abstract][Full Text] [Related]
6. Cardiometabolic profile of non-functioning and autonomous cortisol-secreting adrenal incidentalomas. Is the cardiometabolic risk similar or are there differences?
Araujo-Castro M; Robles Lázaro C; Parra Ramírez P; Cuesta Hernández M; Sampedro Núñez MA; Marazuela M
Endocrine; 2019 Dec; 66(3):650-659. PubMed ID: 31473918
[TBL] [Abstract][Full Text] [Related]
7. Predictors of Tumour Growth and Autonomous Cortisol Secretion Development during Follow-Up in Non-Functioning Adrenal Incidentalomas.
Araujo-Castro M; Parra Ramírez P; Robles Lázaro C; García Centeno R; Gracia Gimeno P; Fernández-Ladreda MT; Sampedro Núñez MA; Marazuela M; Escobar-Morreale HF; Valderrabano P
J Clin Med; 2021 Nov; 10(23):. PubMed ID: 34884211
[TBL] [Abstract][Full Text] [Related]
8. Clinical features, risk of mass enlargement, and development of endocrine hyperfunction in patients with adrenal incidentalomas: a long-term follow-up study.
Falcetta P; Orsolini F; Benelli E; Agretti P; Vitti P; Di Cosmo C; Tonacchera M
Endocrine; 2021 Jan; 71(1):178-188. PubMed ID: 32915435
[TBL] [Abstract][Full Text] [Related]
9. Increased mortality in patients with adrenal incidentalomas and autonomous cortisol secretion: a 13-year retrospective study from one center.
Patrova J; Kjellman M; Wahrenberg H; Falhammar H
Endocrine; 2017 Nov; 58(2):267-275. PubMed ID: 28887710
[TBL] [Abstract][Full Text] [Related]
10. Clinical course of patients with adrenal incidentalomas and cortisol autonomy: a German retrospective single center cohort study.
Remde H; Kranz S; Morell SM; Altieri B; Kroiss M; Detomas M; Fassnacht M; Deutschbein T
Front Endocrinol (Lausanne); 2023; 14():1123132. PubMed ID: 37223045
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic accuracy of the different hormonal tests used for the diagnosis of autonomous cortisol secretion.
Araujo-Castro M; García Cano A; Jiménez Mendiguchía L; Escobar-Morreale HF; Valderrábano P
Sci Rep; 2021 Oct; 11(1):20539. PubMed ID: 34654835
[TBL] [Abstract][Full Text] [Related]
12. Performance of DHEAS as a Screening Test for Autonomous Cortisol Secretion in Adrenal Incidentalomas: A Prospective Study.
Liu MS; Lou Y; Chen H; Wang YJ; Zhang ZW; Li P; Zhu DL
J Clin Endocrinol Metab; 2022 Apr; 107(5):e1789-e1796. PubMed ID: 35137142
[TBL] [Abstract][Full Text] [Related]
13. The Steroid Profile of Adrenal Incidentalomas: Subtyping Subjects With High Cardiovascular Risk.
Di Dalmazi G; Fanelli F; Zavatta G; Ricci Bitti S; Mezzullo M; Repaci A; Pelusi C; Gambineri A; Altieri P; Mosconi C; Balacchi C; Golfieri R; Cosentino ER; Borghi C; Vicennati V; Pasquali R; Pagotto U
J Clin Endocrinol Metab; 2019 Nov; 104(11):5519-5528. PubMed ID: 31381072
[TBL] [Abstract][Full Text] [Related]
14. Autonomous cortisol secretion in adrenal incidentalomas and increased visceral fat accumulation during follow-up.
Yener S; Baris M; Peker A; Demir O; Ozgen B; Secil M
Clin Endocrinol (Oxf); 2017 Nov; 87(5):425-432. PubMed ID: 28656620
[TBL] [Abstract][Full Text] [Related]
15. Saliva versus serum cortisol to identify subclinical hypercortisolism in adrenal incidentalomas: simplicity versus accuracy.
Vieira-Correa M; Giorgi RB; Oliveira KC; Hayashi LF; Costa-Barbosa FA; Kater CE
J Endocrinol Invest; 2019 Dec; 42(12):1435-1442. PubMed ID: 31456173
[TBL] [Abstract][Full Text] [Related]
16. Prevalence and incidence of type 2 diabetes mellitus in patients with adrenal incidentalomas: a study of 709 cases.
Brox-Torrecilla N; García Cano AM; Valderrábano P; Quintero Tobar A; Escobar-Morreale HF; Araujo-Castro M
Endocrine; 2023 Sep; 81(3):484-491. PubMed ID: 37212980
[TBL] [Abstract][Full Text] [Related]
17. Age-dependent and sex-dependent disparity in mortality in patients with adrenal incidentalomas and autonomous cortisol secretion: an international, retrospective, cohort study.
Deutschbein T; Reimondo G; Di Dalmazi G; Bancos I; Patrova J; Vassiliadi DA; Nekić AB; Debono M; Lardo P; Ceccato F; Petramala L; Prete A; Chiodini I; Ivović M; Pazaitou-Panayiotou K; Alexandraki KI; Hanzu FA; Loli P; Yener S; Langton K; Spyroglou A; Kocjan T; Zacharieva S; Valdés N; Ambroziak U; Suzuki M; Detomas M; Puglisi S; Tucci L; Delivanis DA; Margaritopoulos D; Dusek T; Maggio R; Scaroni C; Concistrè A; Ronchi CL; Altieri B; Mosconi C; Diamantopoulos A; Iñiguez-Ariza NM; Vicennati V; Pia A; Kroiss M; Kaltsas G; Chrisoulidou A; Marina LV; Morelli V; Arlt W; Letizia C; Boscaro M; Stigliano A; Kastelan D; Tsagarakis S; Athimulam S; Pagotto U; Maeder U; Falhammar H; Newell-Price J; Terzolo M; Fassnacht M
Lancet Diabetes Endocrinol; 2022 Jul; 10(7):499-508. PubMed ID: 35533704
[TBL] [Abstract][Full Text] [Related]
18. Adrenal incidentaloma as a novel independent predictive factor for periodontitis.
Rodrigues MO; Moraes AB; de Paula MP; Pereira VA; Leão ATT; Vieira Neto L
J Endocrinol Invest; 2021 Nov; 44(11):2455-2463. PubMed ID: 33788166
[TBL] [Abstract][Full Text] [Related]
19. Impaired Cognitive Function in Patients With Autonomous Cortisol Secretion in Adrenal Incidentalomas.
Liu MS; Tian ZY; Zhang Z; Yang F; Lou Y; Wang YJ; Zeng YJ; Zhang ZW; Zhu DL; Li P
J Clin Endocrinol Metab; 2023 Feb; 108(3):633-641. PubMed ID: 36263685
[TBL] [Abstract][Full Text] [Related]
20. Management of adrenal incidentalomas: European Society of Endocrinology Clinical Practice Guideline in collaboration with the European Network for the Study of Adrenal Tumors.
Fassnacht M; Arlt W; Bancos I; Dralle H; Newell-Price J; Sahdev A; Tabarin A; Terzolo M; Tsagarakis S; Dekkers OM
Eur J Endocrinol; 2016 Aug; 175(2):G1-G34. PubMed ID: 27390021
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
